Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostatic hyperplasia

Jameel Nazir; Lars Heemstra; Anke van Engen; Zalmai Hakimi; Cristina Ivanescu

首页> 外文期刊>BMC Urology >Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostatic hyperplasia

【24h】

Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostatic hyperplasia

机译：索非那新固定剂量组合和坦洛新口服控制吸附系统口服制剂在伴有前列腺增生的下尿路症状的男性中的成本效益

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《BMC Urology》 |2015年第1期|共页
作者
Jameel Nazir; Lars Heemstra; Anke van Engen; Zalmai Hakimi; Cristina Ivanescu;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. Solifenacin/tamsulosin fixed-dose combination therapy to treat lower urinary tract symptoms in?patients with benign prostatic hyperplasia [J] . Konstantinos Dimitropoulos, Stavros Gravas Drug Design, Development and Therapy . 2015,第5期

机译：Solifenacin / tamsulosin固定剂量联合治疗良性前列腺增生患者的下尿路症状
2. An open-label, prospective interventional study of the tolerability and efficacy of 0.4 mg oral tamsulosin oral controlled absorption system in men with lower urinary tract symptoms associated with benign prostatic hyperplasia who are unsatisfied with treatment with 0.2 mg tamsulosin [J] . Pei-Shan Yang, Chien-Lun Chen, Chen-Pang Hou, Clinical Interventions in Aging . 2018,第2期

机译：一项开放性，前瞻性的干预性研究，研究了0.4 mg口服坦索罗辛口服控制吸收系统对不满意0.2 mg坦索罗辛治疗的下尿路症状与良性前列腺增生有关的男性的耐受性和疗效
3. Responder and health-related quality of life analyses in men with lower urinary tract symptoms treated with a fixed-dose combination of solifenacin and tamsulosin oral- controlled absorption system: results from the NEPTUNE study [J] . Drake Marcus J., Sokol Roman, Coyne Karin, BJU international . 2016,第1期

机译：用索非那新和坦索罗辛口服控制吸收系统固定剂量联合治疗的下尿路症状男性的应答者和健康相关的生活质量分析：NEPTUNE研究的结果
4. Portable Ambulatory Urodynamics Monitoring System for Patients with Lower Urinary Tract Symptoms [C] . Keo-Sik Kim, Chul-Gyu Song, Jeong-Hwan Seo, Toward useful services for elderly and people with disabilities . 2011

机译：便携式尿路动力学监测系统用于下尿路症状患者
5. Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostatic hyperplasia [O] . Jameel Nazir, Lars Heemstra, Anke van Engen, 2015

机译：索非那新固定剂量组合和坦洛新口服控制吸附系统口服制剂在伴有前列腺增生的下尿路症状患者中的成本效益
6. Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostatic hyperplasia [O] . Jameel Nazir, Lars Heemstra, Anke van Engen, 2015

机译：索非那新固定剂量组合和坦洛新口服控制吸附系统口服制剂在伴有前列腺增生的下尿路症状的男性中的成本效益

Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostatic hyperplasia

著录项

引文网络

相似文献

相关主题

期刊订阅